McIlwain Matthew S — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

McIlwain Matthew S has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Profile

Matthew S. McIlwain is listed as a director of Nautilus Biotechnology, Inc. in the company's SEC filings as of June 22, 2026. The filing context available provides the director role but does not include a detailed public biography. There is no public indication in the available context of his death as of the filing date.

Board memberships

• Nautilus Biotechnology, Inc.

Awards & honors

• Director role at Nautilus Biotechnology, Inc. as disclosed in SEC filings (as of 2026-06-22).

Companies — Last 90 Days

• Nautilus Biotechnology, Inc. (NAUT) — 1 filings, last 2026-06-22

Frequently Asked Questions

Who is McIlwain Matthew S?

Matthew S. McIlwain is listed as a director of Nautilus Biotechnology, Inc. in the company's SEC filings as of June 22, 2026. The filing context available provides the director role but does not include a detailed public biography. There is no public indication in the available context of his death as of the filing date.…

How many SEC Form 4 filings has McIlwain Matthew S submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of McIlwain Matthew S's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week